Traders sold shares of CVS Health Corporation (NYSE:CVS) on strength during trading hours on Tuesday. $76.06 million flowed into the stock on the tick-up and $96.34 million flowed out of the stock on the tick-down, for a money net flow of $20.28 million out of the stock. Of all stocks tracked, CVS Health Corporation had the 0th highest net out-flow for the day. CVS Health Corporation traded up $0.82 for the day and closed at $89.99

Several equities research analysts have recently issued reports on the stock. Leerink Swann restated a “buy” rating on shares of CVS Health Corporation in a research note on Friday, June 10th. FBR & Co restated an “outperform” rating and issued a $120.00 price objective on shares of CVS Health Corporation in a research note on Wednesday, August 3rd. Zacks Investment Research raised CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Morgan Stanley reaffirmed a “hold” rating and issued a $104.00 target price on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Finally, Deutsche Bank AG raised their target price on CVS Health Corporation from $99.00 to $108.00 and gave the stock a “hold” rating in a research report on Wednesday, August 3rd. Six research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $113.02.

The company has a market capitalization of $95.95 billion, a P/E ratio of 20.70 and a beta of 0.84. The stock has a 50-day moving average of $94.64 and a 200-day moving average of $97.97.

CVS Health Corporation (NYSE:CVS) last released its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $43.70 billion for the quarter, compared to analyst estimates of $44.28 billion. CVS Health Corporation had a return on equity of 15.86% and a net margin of 2.88%. CVS Health Corporation’s quarterly revenue was up 17.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.19 EPS. Equities research analysts predict that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in CVS. Acrospire Investment Management LLC raised its stake in CVS Health Corporation by 542.2% in the second quarter. Acrospire Investment Management LLC now owns 1,066 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 900 shares during the period. MU Investments Co. Ltd. increased its stake in shares of CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock valued at $109,000 after buying an additional 440 shares in the last quarter. Pinkerton Retirement Specialists LLC increased its stake in shares of CVS Health Corporation by 3,475.0% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,144 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 1,112 shares in the last quarter. D Orazio & Associates Inc. increased its stake in shares of CVS Health Corporation by 9.4% in the second quarter. D Orazio & Associates Inc. now owns 1,160 shares of the pharmacy operator’s stock valued at $111,000 after buying an additional 100 shares in the last quarter. Finally, Cantab Capital Partners LLP increased its stake in shares of CVS Health Corporation by 355.4% in the second quarter. Cantab Capital Partners LLP now owns 1,184 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 924 shares in the last quarter. 80.96% of the stock is currently owned by institutional investors.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.